Nuclera Installs eProtein System at Domainex for Production
04 Nov 2024 //
BUSINESSWIRE
Amphista partners with Domainex to advance drug portfolio
06 Oct 2022 //
PHARMATIMES
Anti-inflammatory drug candidate DMXD-011 shows efficacy in ex-vivo
14 Sep 2022 //
PHARMIWEB
Parkinson’s UK and Domainex join forces to develop neuroinflammation therapies
03 Feb 2022 //
PHARMATIMES
Expansion of APEIRON Biologics and Domainex Partnership will Advance
25 Nov 2020 //
PHARMTECH